Unilab/B-ORG Corp./I-ORG ,/O Norcross/B-GPE ,/O Ga./B-GPE ,/O said/O it/O acquired/O the/O clinical/O laboratories/O of/O closely/O held/O Central/B-ORG Diagnostic/I-ORG Laboratory/I-ORG Inc./I-ORG in/O a/O cash/O and/O securities/O transaction/O valued/O at/O $/O 85/O million/O ./O
Unilab/B-ORG said/O its/O wholly/O owned/O MetWest/B-ORG Inc./I-ORG unit/O paid/O $/O 25/O million/O in/O cash/O ,/O provided/O $/O 30/O million/O in/O notes/O and/O $/O 30/O million/O in/O preferred/O stock/O to/O acquire/O Central/B-ORG 's/O labs/O in/O the/B-LOC Western/I-LOC U.S./I-LOC ./O
Unilab/B-ORG ,/O which/O provides/O clinical/O laboratory/O services/O ,/O competed/O with/O Central/B-ORG ,/O based/O in/O Tarzana/B-GPE ,/O Calif./B-GPE ,/O in/O a/O number/O of/O areas/O ./O
Beyond/O removing/O a/O competitor/O ,/O the/O combination/O should/O provide/O ``/O synergies/O ,/O ''/O said/O Fred/B-PERSON Harlow/I-PERSON ,/O Unilab/B-ORG 's/O chief/O financial/O officer/O ./O
It/O also/O will/O hand/O Unilab/B-ORG new/O markets/O ./O
In/O Los/B-GPE Angeles/I-GPE ,/O for/O example/O ,/O Central/B-ORG has/O had/O a/O strong/O market/O position/O while/O Unilab/B-ORG 's/O presence/O has/O been/O less/O prominent/O ,/O according/O to/O Mr./O Harlow/B-PERSON ./O
